Project Number 5R61AT009628-02 Agency/Funding Organization NCCIH Funding Year 2019 View Full Project Details for Biological signatures of the cognitive effects of Centella asiatica Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) r. Multi-target Researcher and Organization Principal Investigator SOUMYANATH, AMALA Principal Investigator First Name AMALA Principal Investigator Last Name SOUMYANATH Awardee Organization OREGON HEALTH & SCIENCE UNIVERSITY Awardee State Oregon Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-16-418: EXPLORATORY CLINICAL TRIALS AND STUDIES OF NATURAL PRODUCTS IN NCCIH HIGH PRIORITY RESEARCH TOPICS (R61/R33) FY Overall Cost $301,951 Funding Organization Agency/Funding Organization NCCIH Funding Organization Country United States Program Official WEBER, WENDY J Related Resources Clinical Trial Pharmacokinetics Centella Asiatica Product (CAP) in Mild Cognitive Impairment
